New research from Imperial suggests that components of the immune system involved in allergic reactions may be projective against skin cancer. The early-stage study (led by Dr Jessica Strid and co-authored by Immunology Theme Lead Professor Marina Botto), published in the journal Nature Immunology, may also provide clues as to why allergies are on the […]
The foundation of immunotherapy is based on the ability to manipulate the immune system to fight diseases that it could not fight on its own. Although the concept was first recognised in the early 20th century, our understanding of the immune response continues to evolve, with many essential response mechanisms yet to be elucidated to […]
The Imperial Confidence in Concept (ICiC) flagship scheme aims to develop Imperial’s early translational research portfolio by providing pilot funding to bridge the gaps between ‘discovery research’ and attraction of follow-on funding for clinical translation of novel therapeutics, devices and diagnostics. These awards form a crucial part of the NIHR Imperial BRC’s translational pipeline, by […]
Over 5 million people in the UK live with arm weakness, which can be caused by stroke, neurological and musculoskeletal conditions. Rehabilitation involves repetitive, task-specific exercises to train arm and hand function. GripAble, developed by NIHR Imperial BRC-supported researchers at Imperial College London, is an electronic handgrip device that connects wirelessly to a range of […]
Non-Alcoholic Fatty Liver Disease (NAFLD) is a type of inflammatory disease where build-up of fat in the liver (called steatosis) is not triggered by excessive alcohol consumption, and results in excessive tissue damage, thereby increasing the risk of developing organ failure, cancer, type 2 diabetes and cardiovascular disease. Early detection of NAFLD is challenging, owing […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.